Literature DB >> 24649301

Malignant bowel obstruction: A retrospective clinical analysis.

Jia-Hong Chen1, Tzu-Chuan Huang1, Ping-Ying Chang1, Ming-Shen Dai1, Ching-Liang Ho1, Yeu-Chin Chen1, Tsu-Yi Chao1, Woei-Yau Kao1.   

Abstract

Malignant bowel obstruction (MBO) is a disease with a poor prognosis, particularly in patients with advanced bowel or gynecological cancers. Multimodality teatments may be used to relieve the symptoms in patients with MBO; however, there is currently no consensus regarding the optimal treatment and no strong evidence supporting the efficacy of any treatment in improving the quality of life (QOL) and prolonging survival. We conducted a search through our medical center database of cancer registries for MBO cases between January, 1995 and December, 2008 and analyzed the clinicopathological characteristics and association between treatments and prognosis or QOL. The primary type of cancer causing MBO was found to be adenocarcinoma of colon. The overall survival time was found to be significantly higher among patients presenting with MBO as the initial symptom and improved QOL was achieved in patients who received surgical treatment. The mean survival time and the functional status of colorectal cancer patients receiving targeted therapy and chemotherapy were more satisfactory compared with those receiving surgery alone or conservative treatment. Furthermore, for end-stage cancer patients with MBO, hospice care was effective in reducing pain scores and relieving the symptoms of the disease.

Entities:  

Keywords:  bowel obstruction; cancer

Year:  2013        PMID: 24649301      PMCID: PMC3915666          DOI: 10.3892/mco.2013.216

Source DB:  PubMed          Journal:  Mol Clin Oncol        ISSN: 2049-9450


  9 in total

1.  Room for improvement? A quality-of-life assessment in patients with malignant bowel obstruction.

Authors:  D Selby; F Wright; K Stilos; P Daines; V Moravan; A Gill; A Chakraborty
Journal:  Palliat Med       Date:  2009-10-01       Impact factor: 4.762

2.  Conservatism of the approximation sigma (O-E)2-E in the logrank test for survival data or tumor incidence data.

Authors:  R Peto; M C Pike
Journal:  Biometrics       Date:  1973-09       Impact factor: 2.571

3.  Phase III trial of prophylactic cranial irradiation compared with observation in patients with locally advanced non-small-cell lung cancer: neurocognitive and quality-of-life analysis.

Authors:  Alexander Sun; Kyounghwa Bae; Elizabeth M Gore; Benjamin Movsas; Stuart J Wong; Christina A Meyers; James A Bonner; Steven E Schild; Laurie E Gaspar; Jeffery A Bogart; Maria Werner-Wasik; Hak Choy
Journal:  J Clin Oncol       Date:  2010-12-06       Impact factor: 44.544

Review 4.  Perceptions of older people with cancer of information, decision making and treatment: a systematic review of selected literature.

Authors:  Z Chouliara; N Kearney; D Stott; A Molassiotis; M Miller
Journal:  Ann Oncol       Date:  2004-11       Impact factor: 32.976

Review 5.  Modern management of cancer-related intestinal obstruction.

Authors:  M P Davis; C Nouneh
Journal:  Curr Oncol Rep       Date:  2000-07       Impact factor: 5.075

6.  Surgery for the palliation of intestinal obstruction in advanced abdominal malignancy.

Authors:  T H Wong; Y M Tan
Journal:  Singapore Med J       Date:  2009-12       Impact factor: 1.858

7.  Management of malignant bowel obstruction.

Authors:  Carla Ida Ripamonti; Alexandra M Easson; Hans Gerdes
Journal:  Eur J Cancer       Date:  2008-03-21       Impact factor: 9.162

8.  Malignant irreversible intestinal obstruction: the powerful association of octreotide to corticosteroids, antiemetics, and analgesics.

Authors:  Catherine Weber; Gilbert B Zulian
Journal:  Am J Hosp Palliat Care       Date:  2008-12-16       Impact factor: 2.500

9.  Palliative management of malignant bowel obstruction in terminally ill patient.

Authors:  Darshit A Thaker; Bruce C Stafford; Luke S Gaffney
Journal:  Indian J Palliat Care       Date:  2010-05
  9 in total
  3 in total

1.  Surgical management of malignant bowel obstruction in recurrent pancreatic cancer.

Authors:  Hyung Sun Kim; Joon Seong Park; Jin Hong Lim; Ja Hoon Back; Dong Sup Yoon
Journal:  Int J Surg Case Rep       Date:  2017-01-12

2.  Intussusception as a rare cause of bowel obstruction in a woman with recurrent ovarian cancer.

Authors:  Mackenzie W Sullivan; Susan C Modesitt
Journal:  Gynecol Oncol Rep       Date:  2018-08-11

3.  Surgical intervention for malignant bowel obstruction caused by gastrointestinal malignancies.

Authors:  Peng-Ju Chen; Lin Wang; Yi-Fan Peng; Nan Chen; Ai-Wen Wu
Journal:  World J Gastrointest Oncol       Date:  2020-03-15
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.